Lataa...
Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology?
BACKGROUND: Gonadotropin-releasing hormone (GnRH) agonist triggering plus 1,500 IU human chorionic gonadotropin (hCG) supplementation protocol was previously claimed effective in reducing the ovarian hyperstimulation syndrome (OHSS) incidence in high responders. METHODS: This retrospective study inc...
Tallennettuna:
| Julkaisussa: | J Clin Med Res |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elmer Press
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4817580/ https://ncbi.nlm.nih.gov/pubmed/27081426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2500w |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|